News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Results of the SARAH trial presented today demonstrate that SIRT resulted in median overall survival…
Results from the CheckMate 040 study found that nivolumab, an immuno-oncology drug which acts by…
In March oncologists, haematologists, palliative care and pain specialists gathered in Barcelona – as well…
The total number of cancer cases diagnosed among people living with the human immunodeficiency virus…
Treatment with a combination of ipilimumab (Yervoy) and Coxsackievirus A21 (CVA21; Cavatak) led to durable…
Treatment with the immune checkpoint inhibitor nivolumab (Opdivo) yielded durable responses in some patients with…
University of Colorado Cancer Center researchers presented the results of a phase II clinical trial…
Among patients with advanced melanoma, those who received both nivolumab (Opdivo) and ipilimumab (Yervoy) had…
Patients with glioblastoma who wore a medical device that delivers alternating electrical fields in addition…
Although most patients with relapsed B-cell acute lymphoblastic leukaemia (B-ALL) experienced complete response after treatment…